News. 28/04/22

Procuritas partners with Nordic Biomarker

Procuritas Capital Investors (“Procuritas”) is pleased to announce that it has taken a majority stake in Nordic Biomarker, a fast-growing Swedish supplier of advanced reagents for IVD coagulation analyzers with a clear sustainability-driven purpose.  

Nordic Biomarker was founded in 2007 to meet market demand for an independent OEM-supplier of high-quality reagents for coagulation analyzers. The company has a growing product portfolio of routine and specialty reagents for IVD coagulation testing. In 2017, Nordic Biomarker teamed up with Medirox, adding CE-marked reagent kits to the product offering. Products are delivered to clients around the world for sale under their own brand names as well as to distributors of its portfolio of Medirox branded kits. Production is performed in-house at Nordic Biomarker’s new facilities in Umeå and in Linköping, Sweden. Nordic Biomarker is investing significantly in research and development of new products and has several new products in pipeline. The company had revenue of 131M SEK in 2021 and has approximately 80 employees. 

Procuritas has a strong track record of investing in companies that have the potential for transformational growth, in this instance to grow from a niche leader to a global challenger in coagulation testing through organic growth as well as M&A. The investment in Nordic Biomarker aligns with Procuritas’ target to support the UN Sustainable Development Goals and fits in with #3 “To ensure healthy lives and promote well-being at all ages”.  

Rikard Rodén, CEO, commented: “We are really proud to be partnering with Procuritas who have a fantastic track record of supporting businesses on their growth journey and making sure their potential is realized.  We have built up a great partnership over the past months and really look forward to working together.” 

Johan Conradsson, Co-Managing Partner at Procuritas, commented: “With our ageing population and the trend towards science-based health testing, we see great opportunities for Nordic Biomarker to continue its impressive journey. The company has high-quality products for patients and holds a unique and competitive position in a growing market. We see a great future for this business.”

For further information, please contact:

Johan Conradsson
johan.conradsson@procuritas.com

About Procuritas
Procuritas is a mid-market Nordic private equity investor, building up regional service champion and global niche leaders through transformative growth.  As the longest-established private equity firm in the Nordics with a 35-year track record, Procuritas has carefully invested in more than 45 companies, accelerated their growth and helped them to realize their true business potential. The long-serving team is characterized by its passion for business, hands-on experience, enthusiasm, commitment to ESG-linked value creation initiatives and strong belief that they are allies in the quest to build strong and sustainable businesses.  Read more at www.procuritas.com.  

About Nordic Biomarker
Nordic Biomarker is a Swedish original manufacturer of advanced reagents, calibrators and controls for coagulation analyzers and offers products used for a wide range of routine and specialty tests. The company’s expertise covers all relevant technology areas, and prides itself on being experts when it comes to both immunological, chromogenic as well as clotting assays. Read more at www.nordicbiomarker.com. 

 

More news.

23/08/24

PropTech Energy expands within the Stockholm region through the acquisition of Alova

PropTech Energy are pleased to announce the acquisition of Alova, a rapidly growing player in technical service and maintenance for properties. This strategic acquisition strengthens PropTech Energy’s presence in the Stockholm region and enhances the group’s capacity to offer high-quality technical solutions to property owners. Alova has established itself as a leading player in the...

 03/06/24

Pierre Nyström joins PropTech Energy as Group CEO

PropTech Energy is a one-stop shop for indoor climate, energy efficiency and other property services, consisting of Ömangruppen, Axcell Fastighetspartner and P2 Energi. The company is currently on a growth journey both organically and through strategic M&A-activities in the Nordics. Today, we are pleased to announce that Pierre Nyström joins PropTech Energy as Group CEO....

 28/05/24

Our SBTi targets approved

Procuritas is proud to announce that our science-based targets have been officially approved. These targets are set in accordance with the SBTi sector-specific standard for financial institutions, underscoring Procuritas’ commitment to sustainability and climate responsibility. The approved targets mandate that all Procuritas portfolio companies must establish and have their own science-based targets verified by the...